Our medical co-pay program is a simple process that follows these steps: We also provide ongoing adherence coaching for patients to help them overcome barriers, set expectations and deter drop off. We engage and educate provider staff in the processes of enrollment, claims submission and Our team of experts will work to understand your financial support needs, building an integrated co-pay solution to help you serve patients and promote loyalty. Depending on a patient’s product portfolioĪnd provider coverage, brands may offer medical or pharmacy benefit support-or both. Specialty brands often require medical benefit co-pay programs, particularly for infused and in-office administered products.
LoyaltyScript, McKesson's market-leading pharmacy co-pay solution We offer programs for pharmacy co-pay and medical benefit co-pay, and we work with you to determine how they can best support your business. McKesson can help you ensure patients can overcome the barriers to medication adherence. The more you can do to support a patient’s ability to adhere to their medication, the better their outcome and the more your business can grow In addition, in isolated cases, there was a development of hallucinations, psychosis and loss of consciousness, bradycardia, heart failure, atrioventricular conduction disorders, excessive blood pressure lowering, exacerbation of intermittent claudication, dyspepsia, vomiting, nausea, stool disorders, flatulence, bronchospasm, Quincke's edema, Erythema, urticaria, exacerbation of psoriasis, increased fatigue, impotence, swelling, dry eye, mucous cyanosis of the extremities.įor patients who use contact lenses, in case of eye mucosa dryness developing, it is recommended to use artificial tears or wear glasses during Bystolic therapy.As a pharmaceutical manufacturer, your business depends on patients having access to the medications they need. However, Bystolic may cause the possibility of developing such undesirable effects as: depressive conditions, nightmares, headache, paresthesia, dizziness, asthenia, syncope, decreased visual acuity. If there’s a need of cancelling Bystolic treatment, the dose is recommended to be reduced gradually as the abrupt cancellation can lead to a temporary increase in the symptoms of heart failure.īystolic is not used for the treatment in patients with intolerance to the active ingredient of the drug, glucose-galactose absorption disorder, lactase deficiency, and galactoseemia hepatic dysfunction, cardiogenic shock, sinus node weakness syndrome, second- and third-degree atrioventricular blockade without an artificial sinoatrial node, compensated heart failure.īystolic is not used to treat patients with bronchial asthma and with a tendency of bronchospasm development, untreated pheochromocytoma, metabolic acidosis, bradycardia, arterial hypotension, as well as severe peripheral blood flow disorders, congestive heart failure, peripheral circulatory disorders, atrioventricular blockade of the first degree, and Prinzmetal’s anginaĪs a rule, Bystolic is well tolerated by patients. If in four weeks after the beginning of therapy with Bystolic, the arterial pressure control is insufficient, additional therapy is prescribed including the recommended combination of Bystolic in a standard daily dose with hydrochlorothiazide in a daily dose of 12.5-25mg. Adults with an essential form of arterial hypertension are usually recommended to take 5mg of Bystolic a day. The duration of therapy as well as the dosage of Bystolic is determined by doctor. As a rule, the daily dose of Bystolic is prescribed for single take.
It is recommended to take the drug at the same time of a day. Bystolic pills can be taken regarless of food intake regime. Bystolic can be prescribed in a complex therapy of elderly patients with stable chronic heart failure of moderate severity.īystolic is taken orally. With prolonged therapy, the hypotensive effect of Bistolic does not change.īystolic is used to treat patients with an essential form of hypertension. Bystolic helps to reduce heart rate, reduces arterial pressure at rest and during exercising regardless the initial level of arterial pressure.
0 kommentar(er)
